Although a role has not been assigned to this cell population in breast cancer, previous studies in other tumor types suggest that CD27 co-expression on the surface of CD8+ T cells directly correlates with the ability of these CD8+ T cells to mediate tumor regression (48). Here, CD8A is linked to breast carcinoma.